Print

HVTN 068

A Phase I Clinical Trial to Evaluate Immune Response Kinetics and Safety of Two Different Primes, Adenoviral Vector Vaccine (VRC-HIVADV014-00-VP) and DNA Vaccine (VRC-HIVDNA009-00-VP), Each Followed by Adenoviral Vector Boost in Healthy, HIV-1 Uninfected Adults

Trial Details:

IIa Completed
National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC), HIV Vaccine Trials Network (HVTN) February 03, 2006
VRC-HIVADV014-00-VP,VRC-HIVDNA009-00-VP DNA gag B, gol B, nef B, env A, env B, env C ; Ad5 Gag-Pol Env A/B/C
VRC-HIVADV014-00-VP Viral Vector - Adeno
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA 66
NCT00270218
ClinicalTrials.gov